175 related articles for article (PubMed ID: 10982780)
1. Gastroenterologists and choosing the right bisphosphonate.
Leder BZ; Kronenberg HM
Gastroenterology; 2000 Sep; 119(3):866-9. PubMed ID: 10982780
[No Abstract] [Full Text] [Related]
2. Role of alendronate and risedronate in preventing and treating osteoporosis.
Peters ML; Leonard M; Licata AA
Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of glucocorticoid-induced osteoporosis in 2005.
Orcel P
Joint Bone Spine; 2005 Dec; 72(6):461-5. PubMed ID: 16326129
[TBL] [Abstract][Full Text] [Related]
4. Prevention of glucocorticoid-induced osteoporosis.
Saag KG
South Med J; 2004 Jun; 97(6):555-8. PubMed ID: 15255421
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for osteoporosis.
Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
[TBL] [Abstract][Full Text] [Related]
6. Treating osteoporosis in post-menopausal women: a case approach.
Keller MI
Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489
[TBL] [Abstract][Full Text] [Related]
7. [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
Trémollières F
Gynecol Obstet Fertil; 2001 Nov; 29(11):846-52. PubMed ID: 11770280
[No Abstract] [Full Text] [Related]
8. Bisphosphonates.
Diez-Perez A
Maturitas; 2002 Aug; 43 Suppl 1():S19-26. PubMed ID: 12361885
[No Abstract] [Full Text] [Related]
9. [Osteoporosis].
Bartl R
Internist (Berl); 2002 Dec; 43(12):1529-30, 1533-43. PubMed ID: 12607392
[No Abstract] [Full Text] [Related]
10. Bisphosphonate therapy.
Licata AA
Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
[TBL] [Abstract][Full Text] [Related]
11. Iatrogenic osteoporosis.
Hamdy RC
South Med J; 1999 Nov; 92(11):1131-3. PubMed ID: 10586849
[No Abstract] [Full Text] [Related]
12. Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.
Chapurlat RD
Treat Endocrinol; 2005; 4(2):115-25. PubMed ID: 15783248
[TBL] [Abstract][Full Text] [Related]
13. [Osteoporosis therapy. Bisphosphonates compared].
MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
[No Abstract] [Full Text] [Related]
14. Glucocorticoid-induced osteoporosis: treatment options and guidelines.
Maricic M
Curr Osteoporos Rep; 2005 Mar; 3(1):25-9. PubMed ID: 16036098
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases.
Cowan S; Morin S; Ernst P
Thorax; 1998 May; 53(5):331-2. PubMed ID: 9708219
[No Abstract] [Full Text] [Related]
16. Risedronate: a new oral bisphosphonate.
Roll KT
Clin Ther; 2002 May; 24(5):835-6. PubMed ID: 12075950
[No Abstract] [Full Text] [Related]
17. Parathyroid hormone.
Madore GR; Sherman PJ; Lane JM
J Am Acad Orthop Surg; 2004; 12(2):67-71. PubMed ID: 15089079
[No Abstract] [Full Text] [Related]
18. Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.
Rackoff PJ; Sebba A
Treat Endocrinol; 2005; 4(4):245-51. PubMed ID: 16053341
[TBL] [Abstract][Full Text] [Related]
19. Summaries for patients. Drug therapy for osteoporosis.
Ann Intern Med; 2008 May; 148(9):I28. PubMed ID: 18458273
[No Abstract] [Full Text] [Related]
20. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
[No Abstract] [Full Text] [Related]
[Next] [New Search]